Ladies on Laptop

STUDIES

Below you will find all of our current and past self-advocacy studies. If you are interested in joining a study and think you may be eligible, feel free to call us at 412-624-0297. You are also welcome to email us at selfadvocacy@pitt.edu. Be sure to include the title of the study in the subject line.

Current

STRONG

AYA

Peer Navigation

Past

Self-Advocacy Serious Game Pilot Study

Male Self-Advocacy Study

Self-Advocacy Scale

Self-Advocacy Framework

Partnered Research

Nurses are invited to join our study!

Hello Nurses,

This research study aims to understand work experiences among nurses with cancer. For that reason, we will be surveying nurses diagnosed with invasive cancer within the past three years to complete a one-time online 60-minute survey. Each participant will receive a $10 Amazon gift card as a token of our appreciation. This is an entirely anonymous questionnaire, so your responses will not be identifiable in any way.

If you are interested in being part of the study, please complete the screening form by scanning the QR Code or going to this website: https://redcap.link/nursecancerstudy. This screening form will take around 3 minutes and help us understand if you meet our study's inclusion criteria.

This study is being conducted by Kai-Lin You, who can be reached at kailinyou@pitt.edu or 412-624-0279, if you have any questions.

Principal Investigator:
Kai-Lin You, PhD(c), MSN, RN
University of Pittsburgh School of Nursing  
kailinyou@pitt.edu
412-624-0279

Study Team Members (in alphabetical order):
Andrew Dierkes, PhD, RN
Catherine M. Bender, PhD, RN, FAAN
Hawley Zurlo
Ketki Raina, PhD, OTR/L, FAOTA
Laura A. Fennimore, DNP, RN, NEA-BC, FAAN
Margaret Rosenzweig, PhD, CRNP-C, AOCNP, FAAN
Paul Wesley Scott, PhD
Teresa Hagan Thomas, PhD, RN
Tracey Wangechi Maina.

This study [IRB No. STUDY22060092] is supported by the 2022 Sigma/Council for Advancement of Nursing Science grant and University of Pittsburgh School of Nursing [Margaret E. Wilkes Scholarship Fund Award FY22].